mercredi 20 juin 2018

Onco Actu du 20 juin 2018


1.1 Biologie - Gènes

New human gene tally reignites debate [Nature]

2.10 Etiologie - Alcool

The association of lifetime alcohol use with mortality and cancer risk in older adults: A cohort study [PLoS Medicine]

What drinking alcohol means for your cancer and death risk [CNN]

4. Dépistage, diagnostic et pronostic

Benjamin Mazer: Theranos’ dystopian vision lives on [BMJ Blogs]

5.12.2 Immunothérapies - CAR-T, thérapies cellulaires

News outlets focus on one dramatic outcome. But did researchers omit data from hundreds in clinical trial? [HealthNewsReview]

5.12.5 Immunothérapies - Pharma

I/O player iTeos lines up a $75M round as it preps for human studies, plans a leap to US hub [EndPoints]

5.12.6 Immunothérapies - AMM

Amgen Receives European Commission Approval To Add Overall Survival Data To BLINCYTO® (blinatumomab) Label [Amgen]

5.2 Pharma

Latecomer Sanofi looks to catch next wave of cancer therapies [Reuters]

5.2.2 Pharma - Fusions & Acquisitions

In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine [Xconomy]

6.1 Observation

Survival rate for most common type of pancreatic cancer is half as good as previously thought [The Telegraph]

6.3 Associations/Fondations

What Do Foundations Have In Mind With The Phrase “Social Determinants of Health”? [Health Affairs]

6.6 Publications

How will you judge me if not by impact factor? [Nature]